FirstCry Rebound Tests Whether Margin Pressure Has Peaked
A sharp one-day recovery drew heavy trading, but the longer-term share-price decline and weaker margins remain part of the investment case.
Brainbees Solutions, the parent of FirstCry, rose as much as 12.7% to ₹178.70 on the NSE, ending a three-session losing streak as benchmark indices also surged. The move came after mixed Q2 FY27 results: revenue grew and losses narrowed, but gross-margin pressure weighed on adjusted Ebitda. JM Financial believes the worst may be behind the company, while trimming its estimates and target price.
A high-volume bounce, not yet a change in the longer trend
Brainbees Solutions shares climbed sharply in Tuesday’s session, in line with the broad rise in benchmark indices. The stock reached ₹178.70, up 12.7% at its peak, and was last reported at ₹175.67, a gain of 10.7%. Trading was unusually active: 42.36 million shares had changed hands by 11.30 am, placing the company among the NSE’s top three volume gainers.
That activity suggests strong investor interest in the rebound, but it does not by itself establish that selling pressure has ended. The shares had fallen for three consecutive sessions before Tuesday’s advance. They remain down 39% year to date and 47% over one year, and were still 61.5% below their ₹465 issue price even after reaching the session high. The scale of that decline puts the day’s rally in perspective.
Revenue growth came with a margin setback
The Q2 FY27 results presented a mixed picture. Revenue increased 14.1% year on year to ₹2,395.8 crore, while the net loss narrowed to ₹12.6 crore from ₹50.5 crore in the year-earlier quarter. Those improvements indicate progress on sales and losses, but did not remove concerns about the quality and profitability of growth.
JM Financial noted that gross merchandise value, or GMV, grew 9%, with festive demand partly shifting into Q3 FY27. Gross margin fell 310 basis points year on year, which the analysts linked to residual diaper discounting and crude-related cost pressures. Adjusted Ebitda margin declined 220 basis points to 6.9%. For investors, the central question is whether the demand timing and cost pressures ease enough to support a recovery in margins, rather than merely stronger reported revenue.
JM Financial sees scope for recovery, but cuts estimates
JM Financial reduced its FY27 adjusted Ebitda estimate by about 18% after the gross-margin miss, while broadly retaining its FY28–29 estimates. Its view that the worst is likely behind the company rests on expectations that diaper discounting will moderate, crude-linked cost pressure will ease and price pass-throughs will catch up. These are expectations, not outcomes already reflected in the results.
The brokerage also cut adjusted PAT estimates by about 62% for FY27, 12% for FY28 and 11% for FY29. It attributed the sharper FY27 revision to a low base and higher spending on offline stores. JM Financial lowered its September 2027 target price to ₹245 from ₹255 and maintained a Buy rating. The revised target and earnings estimates show that its constructive outlook is accompanied by near-term caution.
What investors should watch next
Management said diapering intensity had moderated from Q2 FY27 and that online and offline gross margins had recovered about 100 basis points versus Q3 FY26, with further improvement expected through Q3 and Q4 FY27. Progress on those measures will matter more than a single-session share-price move. Investors can also track whether the delayed festive demand translates into stronger GMV and whether margin recovery is sustained.
The shares’ distance from the issue price and their steep declines over the year underline the market’s reassessment of the business. Tuesday’s jump may reflect renewed interest, but a durable recovery would require evidence that operating pressures are easing and earnings estimates have stabilised.
Key Highlights
- Brainbees shares gained as much as 12.7%, ending a three-session slide.
- Trading volume reached 42.36 million shares by 11.30 am.
- Q2 FY27 revenue rose 14.1% to ₹2,395.8 crore; the net loss narrowed to ₹12.6 crore.
- Gross margin declined 310 basis points year on year, while adjusted Ebitda margin fell to 6.9%.
- JM Financial cut its FY27 adjusted Ebitda estimate by about 18% and its target price to ₹245, retaining Buy.
Investor Note: The rally offers a reason to reassess Brainbees, not to assume its recovery is complete. Investors may want to weigh the company’s revenue growth and narrowing losses against margin pressure, forecast cuts and the execution still required to deliver the expected improvement.
Stay Ahead of the Market 📈
Subscribe to our weekly newsletter
Get your weekly market summary from FinBrooks Insights and smart financial lessons from FinBrooks Academy delivered straight to your inbox every weekend!